Director
Director at BridgeBio Pharma, Inc., filing insider transactions between 2025-11-17 and 2026-05-15.
| SEC ↗ |
| 2026-05-15 | BBIO | Sale | 6,200 | $66.69 | $413K | SEC ↗ |
| 2026-02-17 | BBIO | Sale | 4,793 | $75.57 | $362K | SEC ↗ |
| 2026-02-17 | BBIO | Sale | 1,900 | $74.34 | $141K | SEC ↗ |
| 2026-02-17 | BBIO | Sale | 3,307 | $75.93 | $251K | SEC ↗ |
| 2025-11-17 | BBIO | Sale | 3,801 | $66.25 | $252K | SEC ↗ |
| 2025-11-17 | BBIO | Sale | 6,199 | $66.89 | $415K | SEC ↗ |